The DOI matches its Crossref record; 91 of the 91 references it cites were found in a registry or an index.
Vancomycin-resistant enterococcal infections: epidemiology, clinical manifestations, and optimal management
Open accessAbstract
Since its discovery in England and France in 1986, vancomycin-resistant Enterococcus has increasingly become a major nosocomial pathogen worldwide. Enterococci are prolific colonizers, with tremendous genome plasticity and a propensity for persistence in hospital environments, allowing for increased transmission and the dissemination of resistance elements. Infections typically present in immunosuppressed patients who have received multiple courses of antibiotics in the past. Virulence is variable, and typical clinical manifestations include bacteremia, endocarditis, intra-abdominal and pelvic infections, urinary tract infections, skin and skin structure infections, and, rarely, central nervous system infections. As enterococci are common colonizers, careful consideration is needed before initiating targeted therapy, and source control is first priority. Current treatment options including linezolid, daptomycin, quinupristin/dalfopristin, and tigecycline have shown favorable activity against various vancomycin-resistant Enterococcus infections, but there is a lack of randomized controlled trials assessing their efficacy. Clearer distinctions in preferred therapies can be made based on adverse effects, drug interactions, and pharmacokinetic profiles. Although combination therapies and newer agents such as tedizolid, telavancin, dalbavancin, and oritavancin hold promise for the future treatment of vancomycin-resistant Enterococcus infections, further studies are needed to assess their possible clinical impact, especially in the treatment of serious infections.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hidron, A. I., Edwards, J. R., Patel, J., Horan, T. C., Sievert, D. M., Pollock, D. A., Fridkin, S. K., & National Healthcare Safety Network Team and Participating National Healthcare Safety Network Facilities (2008) · Infection Control & Hospital Epidemiology · doi:10.1086/591861 · Cited by 3,724
How long do nosocomial pathogens persist on inanimate surfaces? A systematic review
Kramer, A., Schwebke, I., & Kampf, G. (2006) · BMC Infectious Diseases · doi:10.1186/1471-2334-6-130 · Cited by 2,504
The life and times of the Enterococcus
Murray, B. E. (1990) · Clinical Microbiology Reviews · doi:10.1128/cmr.3.1.46 · Cited by 1,908
Baddour, L. M., Wilson, W. R., Bayer, A. S., Fowler, V. G., Bolger, A. F., Levison, M. E., Ferrieri, P., Gerber, M. A., Tani, L. Y., Gewitz, M. H., et al. (2005) · Circulation · doi:10.1161/circulationaha.105.165564 · Cited by 1,707
Sievert, D. M., Ricks, P., Edwards, J. R., Schneider, A., Patel, J., Srinivasan, A., Kallen, A., Limbago, B., Fridkin, S., & National Healthcare Safety Network (NHSN) Team and Participating NHSN Facilities (2013) · Infection Control & Hospital Epidemiology · doi:10.1086/668770 · Cited by 1,582
Molecular mechanisms that confer antibacterial drug resistance
Walsh, C. (2000) · Nature · doi:10.1038/35021219 · Cited by 1,578
Plasmid-Mediated Resistance to Vancomycin and Teicoplanin in Enterococcus Faecium
Leclercq, R., Derlot, E., Duval, J., & Courvalin, P. (1988) · New England Journal of Medicine · doi:10.1056/nejm198807213190307 · Cited by 1,425
The ecology, epidemiology and virulence of Enterococcus
Fisher, K., & Phillips, C. (2009) · Microbiology · doi:10.1099/mic.0.026385-0 · Cited by 1,227
VANCOMYCIN-RESISTANT ENTEROCOCCI
Uttley, A. C., Collins, C. H., Naidoo, J., & George, R. C. (1988) · The Lancet · doi:10.1016/s0140-6736(88)91037-9 · Cited by 1,226
Vancomycin-Resistant Enterococci
Cetinkaya, Y., Falk, P., & Mayhall, C. G. (2000) · Clinical Microbiology Reviews · doi:10.1128/cmr.13.4.686 · Cited by 1,163
Cited by
Antimicrobial Resistance in ESKAPE Pathogens
De Oliveira, D. M. P., Forde, B. M., Kidd, T. J., Harris, P. N. A., Schembri, M. A., Beatson, S. A., Paterson, D. L., & Walker, M. J. (2020) · Clinical Microbiology Reviews · doi:10.1128/cmr.00181-19 · Cited by 2,078
Antibiotic Resistance in Bacteria—A Review
Urban-Chmiel, R., Marek, A., Stępień-Pyśniak, D., Wieczorek, K., Dec, M., Nowaczek, A., & Osek, J. (2022) · Antibiotics · doi:10.3390/antibiotics11081079 · Cited by 580
The Surgical Infection Society Revised Guidelines on the Management of Intra-Abdominal Infection
Mazuski, J. E., Tessier, J. M., May, A. K., Sawyer, R. G., Nadler, E. P., Rosengart, M. R., Chang, P. K., O'Neill, P. J., Mollen, K. P., Huston, J. M., et al. (2017) · Surgical Infections · doi:10.1089/sur.2016.261 · Cited by 573
Biofilm-associated infection by enterococci
Ch’ng, J.-H., Chong, K. K. L., Lam, L. N., Wong, J. J., & Kline, K. A. (2019) · Nature Reviews Microbiology · doi:10.1038/s41579-018-0107-z · Cited by 447
The Many Faces of Enterococcus spp.—Commensal, Probiotic and Opportunistic Pathogen
Krawczyk, B., Wityk, P., Gałęcka, M., & Michalik, M. (2021) · Microorganisms · doi:10.3390/microorganisms9091900 · Cited by 411
Multidrug-Resistant Bacteria and Alternative Methods to Control Them: An Overview
Vivas, R., Barbosa, A. A. T., Dolabela, S. S., & Jain, S. (2019) · Microbial Drug Resistance · doi:10.1089/mdr.2018.0319 · Cited by 343
Epidemiology of antimicrobial resistance in bloodstream infections
Akova, M. (2016) · Virulence · doi:10.1080/21505594.2016.1159366 · Cited by 292
Current Treatment Strategies Against Multidrug-Resistant Bacteria: A Review
Parmanik, A., Das, S., Kar, B., Bose, A., Dwivedi, G. R., & Pandey, M. M. (2022) · Current Microbiology · doi:10.1007/s00284-022-03061-7 · Cited by 277
Enterococci: Between Emerging Pathogens and Potential Probiotics
Ben Braïek, O., & Smaoui, S. (2019) · BioMed Research International · doi:10.1155/2019/5938210 · Cited by 274
Good microbes, bad genes? The dissemination of antimicrobial resistance in the human microbiome
Crits-Christoph, A., Hallowell, H. A., Koutouvalis, K., & Suez, J. (2022) · Gut Microbes · doi:10.1080/19490976.2022.2055944 · Cited by 156
Faron, M. L., Buchan, B. W., Coon, C., Liebregts, T., van Bree, A., Jansz, A. R., Soucy, G., Korver, J., & Ledeboer, N. A. (2016) · Journal of Clinical Microbiology · doi:10.1128/jcm.01040-16 · Cited by 63
Towards Development of Small Molecule Lipid II Inhibitors as Novel Antibiotics
Chauhan, J., Cardinale, S., Fang, L., Huang, J., Kwasny, S. M., Pennington, M. R., Basi, K., diTargiani, R., Capacio, B. R., MacKerell, A. D., et al. (2016) · PLOS ONE · doi:10.1371/journal.pone.0164515 · Cited by 24
Metadata
- Authors
- Crank, C., & O'Driscoll, T.
- Venue
- Infection and Drug Resistance
- Publisher
- Informa UK Limited
- Published
- 2015-07
- Volume
- 8
- Pages
- 217
- ISSN
- 1178-6973 (ISSN-L)
- OpenAlex
- W2163750088
- Cited by
- 505
- References
- 91
- FWCI
- 14.02
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.